Slingshot members are tracking this event:
Phase 3 data of Revefenacin for COPD due fourth quarter 2016
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|TBPH||Community voting in process|
Revefenacin: Two Phase 3 efficacy studies in COPD (2016)
Slingshot Insights Explained
Oct 20, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3 Data, Revefenacin, Copd